Effect of Intraoperative Opioid Dose on Perioperative Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio in Glioma

References

• Guoping J, Xin L, Yuqian S, Tao S, Shan W. Expression of Glypican-1 in brain glioma and its relationship with clinicopathological features and prognosis. Chin J Mod Med. 2020;30:19–23.
   Google Scholar
• Cata JP, Keerty V, Keerty D, et al. A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non‐small cell lung cancer resection. Cancer Med. 2014;3:900–908. doi:10.1002/cam4.236
   PubMed Web of Science ®Google Scholar
• Silagy AW, Hannum ML, Mano R, et al. Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia. Br J Anaesth. 2020;125:e402–e404. doi:10.1016/j.bja.2020.06.036
   PubMed Web of Science ®Google Scholar
• Zajączkowska R, Leppert W, Mika J, et al. Perioperative immunosuppression and risk of cancer progression: the impact of opioids on pain management. Pain Res Manag. 2018;2018:1–8. doi:10.1155/2018/9293704
   Web of Science ®Google Scholar
• Björkström NK, Strunz B, Ljunggren H-G. Natural killer cells in antiviral immunity. Nat Rev Immunol. 2022;22:112–123. doi:10.1038/s41577-021-00558-3
   PubMed Web of Science ®Google Scholar
• Fang F, Xie S, Chen M, et al. Advances in NK cell production. Cell Mol Immunol. 2022;19:460–481. doi:10.1038/s41423-021-00808-3
   PubMed Web of Science ®Google Scholar
• Maher DP, Walia D, Heller NM. Suppression of human natural killer cells by different classes of opioids. Anesth Analg. 2019;128:1013–1021. doi:10.1213/ANE.0000000000004058
   PubMed Web of Science ®Google Scholar
• Plein LM, Rittner HL. Opioids and the immune system – friend or foe. Br J Pharmacol. 2018;175:2717–2725. doi:10.1111/bph.13750
   PubMed Web of Science ®Google Scholar
• Gonda TA, Tu S, Wang TC. Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle. 2009;8:2005–2013. doi:10.4161/cc.8.13.8985
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–444. doi:10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation. Clin Exp Immunol. 2007;147:227–235. doi:10.1111/j.1365-2249.2006.03261.x
   PubMed Web of Science ®Google Scholar
• García-López L, Adrados I, Ferres-Marco D, Dominguez M. A blueprint for cancer-related inflammation and host innate immunity. Cells. 2021;10:3211. doi:10.3390/cells10113211
   PubMed Web of Science ®Google Scholar
• Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345:196–202. doi:10.1016/j.canlet.2013.08.016
   PubMed Web of Science ®Google Scholar
• Rizzo GEM, Cabibbo G, Craxì A. Hepatitis B virus-associated hepatocellular carcinoma. Viruses. 2022;14:986. doi:10.3390/v14050986
   PubMed Web of Science ®Google Scholar
• Oyouni AAA. Human papillomavirus in cancer: infection, disease transmission, and progress in vaccines. J Infect Public Health. 2023;16:626–631. doi:10.1016/j.jiph.2023.02.014
   PubMed Web of Science ®Google Scholar
• Mandaliya H, Jones M, Oldmeadow C, Nordman IIC. Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI). Transl Lung Cancer Res. 2019;8:886–894. doi:10.21037/tlcr.2019.11.16
   PubMed Web of Science ®Google Scholar
• Portale G, Bartolotta P, Azzolina D, Gregori D, Fiscon V. Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: systematic review and meta-analysis. Langenbecks Arch Surg. 2023;408:85. doi:10.1007/s00423-023-02786-8
   PubMed Web of Science ®Google Scholar
• Hamid HKS, Davis GN, Trejo-Avila M, Igwe PO, Garcia-Marín A. Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: a systematic review and meta-analysis. Surg Oncol. 2021;37:101556. doi:10.1016/j.suronc.2021.101556
   PubMed Web of Science ®Google Scholar
• Lin Z, Ma C, Cao W, Ning Z, Tan G. Prognostic significance of NLR, PLR, LMR and tumor infiltrating T lymphocytes in patients undergoing surgical resection for hilar cholangiocarcinoma. Front Oncol. 2022;12:908907. doi:10.3389/fonc.2022.908907
   PubMed Web of Science ®Google Scholar
• Le VH, Minh TNT, Kha QH, Le NQK. A transfer learning approach on MRI-based radiomics signature for overall survival prediction of low-grade and high-grade gliomas. Med Biol Eng Amp Comput. 2023;61:2699–2712. doi:10.1007/s11517-023-02875-2
   PubMedGoogle Scholar
• Kha Q-H, Le V-H, Hung TNK, Le NQK. Development and validation of an efficient MRI radiomics signature for improving the predictive performance of 1p/19q co-deletion in lower-grade gliomas. Cancers. 2021;13:5398. doi:10.3390/cancers13215398
   PubMed Web of Science ®Google Scholar
• Weng W, Chen X, Gong S, Guo L, Zhang X. Preoperative neutrophil–lymphocyte ratio correlated with glioma grading and glioblastoma survival. Neurol Res. 2018;40:917–922. doi:10.1080/01616412.2018.1497271
   PubMed Web of Science ®Google Scholar
• Gomes Dos Santos A, de Carvalho RF, de Morais ANLR, et al. Role of neutrophil-lymphocyte ratio as a predictive factor of glioma tumor grade: a systematic review. Crit Rev Oncol Hematol. 2021;163:103372. doi:10.1016/j.critrevonc.2021.103372
   PubMed Web of Science ®Google Scholar
• Lei Y, Li Y, Hu Q, Wang J, Sui A. Prognostic impact of neutrophil-to-lymphocyte ratio in gliomas: a systematic review and meta-analysis. World J Surg Oncol. 2019;17:152. doi:10.1186/s12957-019-1686-5
   PubMed Web of Science ®Google Scholar
• Wang D, Kang K, Lin Q, Hai J. Prognostic significance of preoperative systemic cellular inflammatory markers in gliomas: a systematic review and meta‐analysis. Clin Transl Sci. 2020;13:179–188. doi:10.1111/cts.12700
   PubMed Web of Science ®Google Scholar
• Chen J-H, Zhai E-T, Yuan Y-J, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23:6261. doi:10.3748/wjg.v23.i34.6261
   PubMed Web of Science ®Google Scholar
• Sacerdote P. Opioid-induced immunosuppression. Curr Opin Support Palliat Care. 2008;2:14–18. doi:10.1097/SPC.0b013e3282f5272e
   PubMedGoogle Scholar
• Vallejo R, de Leon-Casasola O, Benyamin R. Opioid Therapy and Immunosuppression. Am J Ther. 2004;11:354–365. doi:10.1097/01.mjt.0000132250.95650.85
   PubMedGoogle Scholar
• Malafoglia V, Ilari S, Gioia C, et al. An observational study on chronic pain biomarkers in fibromyalgia and osteoarthritis patients: which role for mu opioid receptor’s expression on NK cells? Biomedicines. 2023;11:931. doi:10.3390/biomedicines11030931
   PubMed Web of Science ®Google Scholar
• Eisenstein TK. The role of opioid receptors in immune system function. Front Immunol. 2019;10:2904. doi:10.3389/fimmu.2019.02904
   PubMed Web of Science ®Google Scholar
• Afsharimani B, Cabot P, Parat M-O. Morphine and tumor growth and metastasis. Cancer Metastasis Rev. 2011;30:225–238. doi:10.1007/s10555-011-9285-0
   PubMed Web of Science ®Google Scholar
• Wang ZY, Wang CQ, Yang JJ, et al. Which has the least immunity depression during postoperative analgesia—morphine, tramadol, or tramadol with lornoxicam? Clin Chim Acta. 2006;369:40–45. doi:10.1016/j.cca.2006.01.008
   PubMed Web of Science ®Google Scholar
• Fuggetta MP, Di Francesco P, Falchetti R, et al. Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells. J Exp Clin Cancer Res CR. 2005;24:255–263.
   PubMed Web of Science ®Google Scholar
• Haroutounian S. Postoperative opioids, endocrine changes, and immunosuppression. PAIN Rep. 2018;3:e640. doi:10.1097/PR9.0000000000000640
   PubMedGoogle Scholar
• Franchi S, Panerai AE, Sacerdote P. Buprenorphine ameliorates the effect of surgery on hypothalamus–pituitary–adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment. Brain Behav Immun. 2007;21:767–774. doi:10.1016/j.bbi.2007.01.001
   PubMed Web of Science ®Google Scholar
• Wodehouse T, Demopoulos M, Petty R, et al. A randomized pilot study to investigate the effect of opioids on immunomarkers using gene expression profiling during surgery. Pain. 2019;160:2691–2698. doi:10.1097/j.pain.0000000000001677
   PubMed Web of Science ®Google Scholar
• Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27–41. doi:10.1016/j.immuni.2019.06.025
   PubMed Web of Science ®Google Scholar
• Yan P, Li J-W, Mo L-G, Huang Q-R. A nomogram combining inflammatory markers and clinical factors predicts survival in patients with diffuse glioma. Medicine. 2021;100:e27972. doi:10.1097/MD.0000000000027972
   PubMed Web of Science ®Google Scholar
• Wang P-F, Song H-W, Cai H-Q, et al. Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival. Oncotarget. 2017;8:50117–50123. doi:10.18632/oncotarget.15235
   PubMedGoogle Scholar
• Gregory AD, McGarry Houghton A. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 2011;71:2411–2416. doi:10.1158/0008-5472.CAN-10-2583
   PubMed Web of Science ®Google Scholar
• Hofman PM. Pathobiology of the neutrophil-intestinal epithelial cell interaction: role in carcinogenesis. World J Gastroenterol. 2010;16:5790. doi:10.3748/wjg.v16.i46.5790
   PubMed Web of Science ®Google Scholar
• Ilie M, Hofman V, Ortholan C, et al. Predictive clinical outcome of the intratumoral CD66b‐positive neutrophil‐to‐CD8‐positive T‐cell ratio in patients with resectable nonsmall cell lung cancer. Cancer. 2012;118:1726–1737. doi:10.1002/cncr.26456
   PubMed Web of Science ®Google Scholar
• Ruffini E, Asioli S, Filosso PL, et al. Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms. Ann Thorac Surg. 2009;87:365–372. doi:10.1016/j.athoracsur.2008.10.067
   PubMed Web of Science ®Google Scholar
• Mony JT, Schuchert MJ. Prognostic implications of heterogeneity in intra-tumoral immune composition for recurrence in early stage lung cancer. Front Immunol. 2018;9:2298. doi:10.3389/fimmu.2018.02298
   PubMed Web of Science ®Google Scholar
• Yanmei X, Tianxiang C, Xiaojing Z, Dezhi L, Jianguo S. Correlation analysis between peripheral blood monocyte number and near-and long-term efficacy of radiotherapy for lung cancer. Chin J Lung Dis. 2014;7:159–164.
   Google Scholar
• Mou L, Zou W, Zhang L, Du D. The value of preoperative blood inflammatory response markers for the diagnosis of different grades of glioma. Tumor Prevent Treat. 2022;35:996–1000.
   Google Scholar
• Bao Y, Yang M, Jin C, et al. Preoperative hematologic inflammatory markers as prognostic factors in patients with glioma. World Neurosurg. 2018;119:e710–e716. doi:10.1016/j.wneu.2018.07.252
   PubMed Web of Science ®Google Scholar
• Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology. 2006;105:660–664. doi:10.1097/00000542-200610000-00008
   PubMed Web of Science ®Google Scholar